Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 85 clinical trials
PET MRI as a Staging Tool for Head and Neck Cancer

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Online studies
  • 0 views
  • 29 Nov, 2021
  • 1 location
  • Online study
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

metastasis
immunological adjuvant
HER2
ESR1
er-positive breast cancer
  • 0 views
  • 04 Dec, 2020
  • 126 locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
pulmonary metastasis
non-small cell lung cancer
measurable disease
small cell lung cancer
  • 0 views
  • 04 Dec, 2020
  • 169 locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
pulmonary metastasis
non-small cell lung cancer
measurable disease
small cell lung cancer
  • 0 views
  • 21 Dec, 2020
  • 52 locations
Identification and Preservation of Arm Lymphatics

Arm lymphedema, local recurrence, regional recurrence, and distant metastasis were recorded at different follow-up examinations.

  • 0 views
  • 05 Aug, 2020
Metastasis-directed Therapy in Castration-refractory Prostate Cancer

The aim is to define the postponement of next line systemic treatment (NEST), by the use of metastasis-directed therapy in patients with oligoprogressive castration-refractory prostate cancer. This will be defined by the NEST-free survival.

metastasis
PET-CT
oligoprogression
enzalutamide
adenocarcinoma of prostate
  • 0 views
  • 16 Feb, 2024
  • 1 location
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

The results will be compared across the 2 arms. Patients with brain metastases are living longer. Maintaining functional independence and brain metastases control is thus increasingly important. Improved radiotherapy treatment techniques could provide better control and survival outcomes whilst maintain QoL and functional capacity.

metastasis
dental caries
MET
cerebral edema
stereotactic radiosurgery
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

This double blind, randomized phase II trial will investigate whether the addition of tocotrienol will improve the effect and lower the toxicity of standard chemotherapy and bevacizumab. Half of the patients will receive tocotrienol and the other half placebo. Treatment is planned for a period of maximum six months and …

metastasis
disseminated cancer
fluorouracil
kidney function test
leucovorin
  • 0 views
  • 16 Feb, 2024
  • 1 location
SBRT for Breast Cancer Oligometastases

This is a prospective data collection of treatment outcome for newly diagnosed oligometastatic breast cancers with 1-3 bone metastases. Eligible patients will be identified from the weekly Breast MDC. Patients will receive the recommended systemic and local treatment (including metastases directed SBRT) according to our clinical practice guidelines.Patients will be …

metastasis
solid tumor
stereotactic body radiation therapy
solid tumors
bone metastases
  • 0 views
  • 05 Aug, 2020
A Trial of Neoadjuvant mXELOXIRI Versus CRT in the EMVI Positive LARC

Extramural Vascular Invasion Positive(EMVI+) is a high risk of distant metastasis for locally advanced rectal cancer(LARC) after resection. The study is to evaluate the efficacy and safety of XELOXIRI as neoadjuvant chemotherapy alone for EMVI+ LARC in contrast to the efficacy of standard Chemoradiotherapy (CRT).

metastasis
adenocarcinoma of rectum
rectal carcinoma
platelet count
chemoradiotherapy
  • 0 views
  • 05 Aug, 2020